MicroRNA-29 and an integrated understanding of atrial fibrillation

Journal of Drugs in Dermatology

Volumn 12, Issue 10, 2013, Pages 1083-

  Hale, Christopher S ^a   Levis, William R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29;

HEART ATRIUM FIBRILLATION; HELPER CELL; HUMAN; LETTER; TH1 CELL; TH17 CELL; TH22 CELL;

ATRIAL FIBRILLATION; CELIAC DISEASE; HUMANS; MICRORNAS; PSORIASIS; T-LYMPHOCYTES;

EID: 84885447114     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Ahlehoff O, Gislason GH, Jorgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2012;33:2054-2064.
2. Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 2011;32:2430-2437.
3. Li H, Scherlag BJ, Kem DC, et al. Atrial tachycardia provoked in the presence of activating autoantibodies to beta2-adrenergic receptor in the rabbit. Heart Rhythm 2013;10:436-441.
4. Liston A, Papadopoulou AS, Danso-Abeam D, Dooley J. MicroRNA-29 in the adaptive immune system: setting the threshold. Cell Mol Life Sci 2012;69:3533-3541.
5. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-1184.
6. Liu L, Lee J, Fu G, et al. Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation. Int Heart J 2012;53:221-224.
7. Dawson K, Wakili R, Ordog B, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013;127:1466-1475, 1475e1461-1428.